Acutus Medical Stock Net Income
| AFIB Stock | USD 0.0002 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Acutus Medical Inc's long-term financial health and intrinsic value.
Acutus |
Acutus Medical Company Net Income Analysis
Acutus Medical Inc's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Acutus Medical Inc Net Income | (11.92 M) |
Most of Acutus Medical Inc's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acutus Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Acutus Medical reported net income of (11.92 Million). This is 103.49% lower than that of the Health Care Equipment & Supplies sector and 105.01% lower than that of the Health Care industry. The net income for all United States stocks is 102.09% higher than that of the company.
Acutus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acutus Medical Inc's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Acutus Medical Inc could also be used in its relative valuation, which is a method of valuing Acutus Medical Inc by comparing valuation metrics of similar companies.Acutus Medical is currently under evaluation in net income category among its peers.
Acutus Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.14 | |||
| Operating Margin | (2.89) % | |||
| Current Valuation | 18.75 M | |||
| Shares Outstanding | 29.72 M | |||
| Shares Owned By Insiders | 3.15 % | |||
| Shares Owned By Institutions | 23.50 % | |||
| Number Of Shares Shorted | 553.6 K | |||
| Price To Book | 0.53 X | |||
| Price To Sales | 0.73 X | |||
| Revenue | 7.16 M | |||
| Gross Profit | (15.55 M) | |||
| EBITDA | (13.49 M) | |||
| Net Income | (11.92 M) | |||
| Cash And Equivalents | 88.97 M | |||
| Cash Per Share | 3.14 X | |||
| Total Debt | 38.48 M | |||
| Debt To Equity | 0.51 % | |||
| Current Ratio | 5.11 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (63.61 M) | |||
| Short Ratio | 0.68 X | |||
| Earnings Per Share | (0.41) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 230 | |||
| Beta | 0.26 | |||
| Market Capitalization | 2.67 M | |||
| Total Asset | 53.96 M | |||
| Retained Earnings | (599.98 M) | |||
| Working Capital | 27.31 M | |||
| Net Asset | 53.96 M |
About Acutus Medical Inc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acutus Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acutus Medical Inc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acutus Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Other Information on Investing in Acutus Pink Sheet
Acutus Medical Inc financial ratios help investors to determine whether Acutus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acutus with respect to the benefits of owning Acutus Medical Inc security.